Abingem 200mg Injection
Abingem 200mg Injection available for export in Toronto, Canada. Trusted supplier of Gemcitabine oncology vials to hospitals, clinics, and pharmaceutical importers.
Composition: Gemcitabine 200mg
Consume Type: Parenteral (For Intravenous Use Only)
Therapeutic Class: Chemotherapy
@ERNESTPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
📧 Email: exports@ernestpharmaceuticals.com
🌐 www.ernestpharmaceuticals.com| www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
📲 WhatsApp: +91 94054 76170
About Abingem 200mg Injection
Abingem 200mg Injection is a cytotoxic anticancer medication containing Gemcitabine, used either as a single agent or in combination with other chemotherapeutic agents for the treatment of various solid tumors. It is indicated for cancers such as breast cancer, pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, and ovarian cancer.
Gemcitabine, the active component of Abingem 200mg Injection, works by interfering with DNA synthesis, inhibiting the replication and growth of rapidly dividing cancer cells. This mechanism helps slow down or stop tumor progression.
The injection is administered intravenously by a qualified healthcare professional in a controlled medical setting. The dosage and treatment schedule are determined by the oncologist based on the patient’s condition, response to therapy, and overall health status.
Uses of Abingem 200mg Injection
Breast cancer
Pancreatic cancer
Non-small cell lung cancer (NSCLC)
Urinary bladder cancer
Ovarian cancer
How Abingem 200mg Injection Works
Abingem 200mg Injection contains Gemcitabine, a nucleoside analog that disrupts DNA synthesis within cancer cells. By incorporating itself into the DNA strands, Gemcitabine prevents further replication and causes programmed cell death (apoptosis). This effectively halts the proliferation of malignant cells while minimizing damage to surrounding healthy tissue.
Medicinal Benefits
Effective against multiple solid tumor types
Can be used as monotherapy or in combination chemotherapy regimens
Demonstrates proven efficacy in advanced and metastatic cancers
Helps control tumor progression and improve survival rates in indicated cancers
Directions for Use
Administered intravenously (I.V.) by a trained medical professional.
Dosage, dilution, and infusion rate should be determined by the treating oncologist.
Do not self-administer.
Possible Side Effects
Common side effects may include:
Nausea or vomiting
Low white blood cell or platelet count
Injection site reaction
Fatigue and fever
Rash or mild skin irritation
Hair loss (alopecia)
Edema (swelling)
Most side effects are temporary and subside as the body adjusts to treatment. Report any persistent or severe adverse reactions to your healthcare provider immediately.
Storage Instructions
Store in a cool, dry place away from sunlight.
Maintain temperature between 10°C – 25°C (non–cold chain).
Keep out of reach of children.
Overdose Information
Since Abingem 200mg Injection is administered by medical professionals, overdose is rare. However, seek immediate medical attention if symptoms such as unusual bleeding, severe rash, signs of infection, or extreme fatigue occur.
Warnings & Precautions
Not recommended in patients with known hypersensitivity to Gemcitabine.
Use with caution in patients with kidney, liver, or heart disorders.
Avoid alcohol consumption during treatment.
Not advised during pregnancy or breastfeeding.
Male patients planning to father a child should consult a doctor regarding fertility preservation before starting therapy.
Inform your doctor about all existing medical conditions and medications, including radiotherapy history.
Diet & Lifestyle Advice
Maintain a balanced diet rich in lean proteins, fruits, and vegetables.
Stay hydrated throughout treatment.
Avoid tobacco and alcohol.
Incorporate light physical activity like walking or yoga, if approved by your doctor.
Prioritize mental health support, as cancer treatment can be emotionally challenging.
Habit Forming
No
